DOI QR코드

DOI QR Code

Cancer-Upregulated Gene 2 (CUG2), a New Component of Centromere Complex, Is Required for Kinetochore Function

  • Kim, Hyejin (Department of Microbiology, Chungnam National University) ;
  • Lee, Miae (Department of Microbiology, Chungnam National University) ;
  • Lee, Sunhee (Department of Microbiology, Chungnam National University) ;
  • Park, Byoungwoo (Department of Microbiology, Chungnam National University) ;
  • Koh, Wansoo (Department of Microbiology, Chungnam National University) ;
  • Lee, Dong Jun (Department of Biological Sciences, Korea Advanced Institute of Science and Technology) ;
  • Lim, Dae-Sik (Department of Biological Sciences, Korea Advanced Institute of Science and Technology) ;
  • Lee, Soojin (Department of Microbiology, Chungnam National University)
  • Received : 2009.04.14
  • Accepted : 2009.04.22
  • Published : 2009.06.30

Abstract

We previously identified cancer-upregulated gene 2 (CUG2) as a commonly up-regulated gene in various human cancer tissues, especially in ovary, liver, and lung (Lee et al., 2007a). CUG2 was determined to be a nuclear protein that exhibited high proto-oncogenic activities when overexpressed in NIH3T3 mouse fibroblast cells. To identify other cellular functions of CUG2, we performed yeast two-hybrid screening and identified CENP-T, a component of CENP-A nucleosome complex in the centromere, as an interacting partner of CUG2. Moreover, CENP-A, the principle centromeric determinant, was also found in complex with CENP-T/CUG2. Immunofluorescent staining revealed the co-localization of CUG2 with human centromeric markers. Inhibition of CUG2 expression drastically affected cell viability by inducing aberrant cell division. We propose that CUG2 is a new component of the human centromeric complex that is required for proper chromosome segregation during mitosis.

Keywords

Acknowledgement

Supported by : Ministry of Science and Technology of Korea, Korea Research Foundation

References

  1. Black, B.E., Foltz, D.R., Chakravarthy, S., Luger, K., Woods, V.L., Jr., and Cleveland, D.W. (2004). Structural determinants for generating centromeric chromatin. Nature 430, 578-582 https://doi.org/10.1038/nature02766
  2. Blower, M.D., Sullivan, B.A., and Karpen, G.H. (2002). Conserved organization of centromeric chromatin in flies and humans. Dev. Cell 2, 319-330 https://doi.org/10.1016/S1534-5807(02)00135-1
  3. Foltz, D.R., Jansen, L.E., Black, B.E., Bailey, A.O., Yates, J.R., 3rd., and Cleveland, D.W. (2006). The human CENP-A centromeric nucleosome- associated complex. Nat. Cell Biol. 8, 458-469 https://doi.org/10.1038/ncb1397
  4. Hori, T., Amano, M., Suzuki, A., Backer, C.B., Welburn, J.P., Dong, Y., McEwen, B.F., Shang, W.H., Suzuki, E., Okawa, K., et al. (2008). CCAN makes multiple contacts with centromeric DNA to provide distinct pathways to the outer kinetochore. Cell 135, 1039-1052 https://doi.org/10.1016/j.cell.2008.10.019
  5. Howman, E.V., Fowler, K.J., Newson, A.J., Redward, S., Mac-Donald, A.C., Kalitsis, P., and Choo, K.H. (2000). Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice. Proc. Natl. Acad. Sci. USA 97, 1148-1153 https://doi.org/10.1073/pnas.97.3.1148
  6. Izuta, H., Ikeno, M., Suzuki, N., Tomonaga, T., Nozaki, N., Obuse, C., Kisu, Y., Goshima, N., Nomura, F., Nomura, N., et al. (2006). Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP-A chromatin of human cells. Genes Cells 11, 673-684 https://doi.org/10.1111/j.1365-2443.2006.00969.x
  7. Kops, G.J., Weaver, B.A., and Cleveland, D.W. (2005). On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5, 773-785 https://doi.org/10.1038/nrc1714
  8. Lee, S., Gang, J., Jeon, S.B., Choo, S.H., Lee, B., Kim, Y.G., Lee, Y.S., Jung, J., Song, S.Y., and Koh, S.S. (2007a). Molecular cloning and functional analysis of a novel oncogene, cancerupregulated gene 2 (CUG2). Biochem. Biophys. Res. Commun. 360, 633-639 https://doi.org/10.1016/j.bbrc.2007.06.102
  9. Lee, K., Shim, J.H., Kang, M.J., Kim, J.H., Ahn, J.S., Yoo, S.J., Kim Kwon, Y., and Kwon, H. (2007b). Association of BAF53 with mitotic chromosomes. Mol. Cells 24, 288-293
  10. Mellone, B., Erhardt, S., and Karpen, G.H. (2006). The ABCs of centromeres. Nat. Cell Biol. 8, 427-429 https://doi.org/10.1038/ncb0506-427
  11. Tomonaga, T., and Nomura, F. (2007). Chromosome instability and kinetochore dysfunction. Histol. Histopathol. 22, 191-197
  12. Yuen, K.W., Montpetit, B., and Hieter, P. (2005). The kinetochore and cancer: what's the connection? Curr. Opin. Cell Biol. 17, 576-582 https://doi.org/10.1016/j.ceb.2005.09.012

Cited by

  1. Sp1 and Sp3 mediate basal and serum-induced expression of human CENP-W vol.37, pp.7, 2009, https://doi.org/10.1007/s11033-010-0008-3
  2. Deacetylation and methylation at histone H3 lysine 9 (H3K9) coordinate chromosome condensation during cell cycle progression vol.31, pp.4, 2011, https://doi.org/10.1007/s10059-011-0044-4
  3. Cug2 is essential for normal mitotic control and CNS development in zebrafish vol.11, pp.None, 2009, https://doi.org/10.1186/1471-213x-11-49
  4. Premitotic Assembly of Human CENPs -T and -W Switches Centromeric Chromatin to a Mitotic State vol.9, pp.6, 2009, https://doi.org/10.1371/journal.pbio.1001082
  5. New Centromeric Component CENP-W Is an RNA-associated Nuclear Matrix Protein That Interacts with Nucleophosmin/B23 Protein vol.286, pp.49, 2009, https://doi.org/10.1074/jbc.m111.228411
  6. Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation vol.43, pp.4, 2013, https://doi.org/10.3892/ijo.2013.2049
  7. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling vol.20, pp.2, 2009, https://doi.org/10.1038/cgt.2012.96
  8. CSN5/JAB1 Interacts with the Centromeric Components CENP-T and CENP-W and Regulates Their Proteasome-mediated Degradation vol.288, pp.38, 2009, https://doi.org/10.1074/jbc.m113.469221
  9. Whole-genome profiling highlights the molecular complexity underlying eccentric cardiac hypertrophy vol.8, pp.3, 2009, https://doi.org/10.1177/1753944714527490
  10. Suppression of autophagic genes sensitizes CUG2-overexpressing A549 human lung cancer cells to oncolytic vesicular stomatitis virus-induced apoptosis vol.44, pp.4, 2014, https://doi.org/10.3892/ijo.2014.2264
  11. Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer vol.71, pp.18, 2009, https://doi.org/10.1007/s00018-014-1605-4
  12. Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling vol.7, pp.30, 2009, https://doi.org/10.18632/oncotarget.10365
  13. Centromere Protein (CENP)-W Interacts with Heterogeneous Nuclear Ribonucleoprotein (hnRNP) U and May Contribute to Kinetochore-Microtubule Attachment in Mitotic Cells vol.11, pp.2, 2016, https://doi.org/10.1371/journal.pone.0149127
  14. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling vol.40, pp.6, 2009, https://doi.org/10.1007/s13402-017-0343-7
  15. Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling vol.8, pp.3, 2017, https://doi.org/10.18632/oncotarget.13867
  16. CENP‐W inhibits CDC25A degradation by destabilizing the SCF β‐TrCP‐1 complex at G 2 /M vol.32, pp.11, 2009, https://doi.org/10.1096/fj.201701358rrr
  17. STAT1-HDAC4 signaling induces epithelial-mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2 vol.40, pp.5, 2018, https://doi.org/10.3892/or.2018.6701
  18. Two major alternative splice variants of beta-TrCP1 interact with CENP-W with different binding preferences vol.41, pp.2, 2009, https://doi.org/10.1007/s13258-018-0748-3
  19. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2-induced oncogenesis through NEK2 and β-catenin vol.54, pp.4, 2009, https://doi.org/10.3892/ijo.2019.4724
  20. Prognostic value of a gene signature in clear cell renal cell carcinoma vol.234, pp.7, 2009, https://doi.org/10.1002/jcp.27700